Increased Pentosidine, an Advanced Glycation End Product, in Plasma and Synovial Fluid from Patients with Rheumatoid Arthritis and Its Relation with Inflammatory Markers

This publication has 17 references indexed in Scilit:

• Implication of an increased oxidative stress in the formation of advanced glycation end products in patients with end-stage renal failure
  Kidney International, 1997
• Glutathione reductase activity, riboflavin status, and disease activity in rheumatoid arthritis.
  Annals of the Rheumatic Diseases, 1996
• Accumulation of albumin-linked and free-form pentosidine in the circulation of uremic patients with end-stage renal failure
  Journal of the American Society of Nephrology, 1996
• Identification of pentosidine as a native structure for advanced glycation end products in beta-2-microglobulin-containing amyloid fibrils in patients with dialysis-related amyloidosis.
  Proceedings of the National Academy of Sciences, 1996
• Involvement of beta 2-microglobulin modified with advanced glycation end products in the pathogenesis of hemodialysis-associated amyloidosis. Induction of human monocyte chemotaxis and macrophage secretion of tumor necrosis factor-alpha and interleukin-1.
  Journal of Clinical Investigation, 1994
• Oxidative DNA damage and cellular sensitivity to oxidative stress in human autoimmune diseases.
  Annals of the Rheumatic Diseases, 1993
• beta 2-Microglobulin modified with advanced glycation end products is a major component of hemodialysis-associated amyloidosis.
  Journal of Clinical Investigation, 1993
• Maillard reaction products and their relation to complications in insulin-dependent diabetes mellitus.
  Journal of Clinical Investigation, 1993
• Accumulation of Maillard reaction products in skin collagen in diabetes and aging.
  Journal of Clinical Investigation, 1993
• Advanced Glycosylation End Products in Tissue and the Biochemical Basis of Diabetic Complications
  New England Journal of Medicine, 1988